Key Takeaways
- • Jefferies raised its price target on Welltower Inc. (NYSE: WELL) to $248 from $237, maintaining a Buy rating and signaling analyst confidence in the real estate investment trust's near-term performance.
- • Multiple analysts have recently adjusted price targets upward, with some firms raising targets as high as $275, reflecting bullish sentiment on the company's fundamentals and durable senior housing demand.
- • Welltower trades at a premium valuation but maintains broad analyst support, with a consensus "Moderate Buy" rating and a median price target of $220.14 across 50 analysts, though estimates range from $145 to $275.
- • The stock has gained 19.3% over the prior three months, suggesting recent momentum as institutional investors respond to improving senior housing market conditions and normalized funds from operations (FFO) growth approaching 25% year-over-year.
Summary
Welltower Inc. has attracted increased analyst support following Jefferies Financial Group's decision to raise its price target to $248 per share from $237, while maintaining a Buy rating. This adjustment reflects analyst Jonathan Petersen's conviction in the senior housing-focused REIT's value proposition amid a durable demand environment for senior living facilities.
The price target increase is part of a broader trend of upward analyst revisions across multiple investment banks. Recent institutional coverage has included targets as high as $275, demonstrating confidence in the company's growth trajectory. UBS also raised its price target on Welltower to $249 from $240 while maintaining a Buy rating, citing both internal operational improvements and favorable market dynamics. These coordinated upgrades indicate a convergence of institutional bullish sentiment on the stock.
As of the most recent data, Welltower closed at $234.50, positioning the stock near its 50-analyst median price target of $220.14, though well below the high estimate of $275. The broader analyst consensus maintains a "Moderate Buy" rating despite the stock trading at a premium valuation, with the street citing 25% year-over-year normalized FFO growth as a key driver of confidence. Over the past three months, WELL shares have appreciated 19.3%, reflecting sustained institutional buying interest aligned with the improving senior housing sector dynamics that underpin analyst forecasts.
The price target increase is part of a broader trend of upward analyst revisions across multiple investment banks. Recent institutional coverage has included targets as high as $275, demonstrating confidence in the company's growth trajectory. UBS also raised its price target on Welltower to $249 from $240 while maintaining a Buy rating, citing both internal operational improvements and favorable market dynamics. These coordinated upgrades indicate a convergence of institutional bullish sentiment on the stock.
As of the most recent data, Welltower closed at $234.50, positioning the stock near its 50-analyst median price target of $220.14, though well below the high estimate of $275. The broader analyst consensus maintains a "Moderate Buy" rating despite the stock trading at a premium valuation, with the street citing 25% year-over-year normalized FFO growth as a key driver of confidence. Over the past three months, WELL shares have appreciated 19.3%, reflecting sustained institutional buying interest aligned with the improving senior housing sector dynamics that underpin analyst forecasts.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.